TLS was associated with increased intra-tumoral CD3 + , CD8 + , CD20 + , decreased infiltration of Foxp3 + and CD68 + cells, and predicted better prognosis in early-stage hepatocellular carcinoma [35]. The gene discussed is CD68; the disease is Tumor Lysis Syndrome.